These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8820526)

  • 1. Metabolic determinants of binge eating.
    Drewnowski A
    Addict Behav; 1995; 20(6):733-45. PubMed ID: 8820526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters.
    Drewnowski A; Krahn DD; Demitrack MA; Nairn K; Gosnell BA
    Am J Clin Nutr; 1995 Jun; 61(6):1206-12. PubMed ID: 7762518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rats that binge eat fat-rich food do not show somatic signs or anxiety associated with opiate-like withdrawal: implications for nutrient-specific food addiction behaviors.
    Bocarsly ME; Berner LA; Hoebel BG; Avena NM
    Physiol Behav; 2011 Oct; 104(5):865-72. PubMed ID: 21635910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binge eating onset in obese patients with binge eating disorder.
    Marcus MD; Moulton MM; Greeno CG
    Addict Behav; 1995; 20(6):747-55. PubMed ID: 8820527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats.
    Boggiano MM; Chandler PC; Viana JB; Oswald KD; Maldonado CR; Wauford PK
    Behav Neurosci; 2005 Oct; 119(5):1207-14. PubMed ID: 16300427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    Malhotra S; King KH; Welge JA; Brusman-Lovins L; McElroy SL
    J Clin Psychiatry; 2002 Sep; 63(9):802-6. PubMed ID: 12363121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement.
    Drewnowski A; Krahn DD; Demitrack MA; Nairn K; Gosnell BA
    Physiol Behav; 1992 Feb; 51(2):371-9. PubMed ID: 1313591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binge eating disorder: a review of the literature after publication of DSM-IV.
    Williamson DA; Martin CK
    Eat Weight Disord; 1999 Sep; 4(3):103-14. PubMed ID: 11234238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label trial of sibutramine in obese patients with binge-eating disorder.
    Appolinario JC; Godoy-Matos A; Fontenelle LF; Carraro L; Cabral M; Vieira A; Coutinho W
    J Clin Psychiatry; 2002 Jan; 63(1):28-30. PubMed ID: 11838622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
    Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
    Trials; 2015 Dec; 16():578. PubMed ID: 26683478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome.
    Mitchell JE; Laine DE; Morley JE; Levine AS
    Biol Psychiatry; 1986 Dec; 21(14):1399-406. PubMed ID: 3539209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats.
    Hagan MM; Holguin FD; Cabello CE; Hanscom DR; Moss DE
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1103-7. PubMed ID: 9408220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour.
    Nathan PJ; Bullmore ET
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):995-1008. PubMed ID: 19433009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of binge eating disorder and psychiatric comorbidity in obese subjects.
    Yanovski SZ; Nelson JE; Dubbert BK; Spitzer RL
    Am J Psychiatry; 1993 Oct; 150(10):1472-9. PubMed ID: 8379549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar, opioids and binge eating.
    Fullerton DT; Getto CJ; Swift WJ; Carlson IH
    Brain Res Bull; 1985 Jun; 14(6):673-80. PubMed ID: 3161588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.
    Lardeux S; Kim JJ; Nicola SM
    Behav Brain Res; 2015 Oct; 292():194-208. PubMed ID: 26097003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and non-clinical binges.
    Jansen A; van den Hout M; Griez E
    Behav Res Ther; 1990; 28(5):439-44. PubMed ID: 2256903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Binge eating disorder (BED)--new diagnostic category].
    Latzer Y; Tzchisinki O
    Harefuah; 2003 Jul; 142(7):544-9, 564. PubMed ID: 12908392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.